Stock Movers Closing Bell: Kenvue Bounces, SoundHound Rallies, Mircon Gives Solid Forecast
Sep 23, 2025
In this episode, Kenvue's stock fluctuated after Trump raised concerns over Tylenol's safety during pregnancy, sparking widespread questions among patients. SoundHound's shares jumped thanks to a new AI partnership with Red Lobster, enhancing their ordering process. Micron also impressed with a strong earnings forecast, driven by demand in the AI sector, surpassing analysts' expectations. The hosts delve into these market-moving events, exploring their implications on the broader US market.
AI Snips
Chapters
Transcript
Episode notes
Micron Outperforms With AI-Driven Guidance
- Micron beat estimates on EPS, revenue, and gross margin for the fiscal fourth quarter.
- The company guided materially higher for the next quarter, citing AI-driven demand and expanding margins.
Doctors Field Patient Calls After Tylenol Comments
- President Trump's remarks provoked patient questions and doctor calls at an Atlanta OB-GYN practice.
- Hosts described doctors fielding a barrage of patient concerns after the comments about Tylenol.
Rely On Evidence For Pregnancy Meds
- Physicians on Bloomberg urged listeners to rely on existing science about acetaminophen in pregnancy.
- Maintain evidence-based care despite high-profile statements suggesting otherwise.